CDIO
Cardio Diagnostics Holdings, Inc. NASDAQ Listed Jan 14, 2022$1.86
-3.06%
vs $1.92
Mkt Cap $5.5M
52w Low $0.97
12.8% of range
52w High $7.91
50d MA $1.87
200d MA $2.18
P/E (TTM)
—
EV/EBITDA
—
P/B
0.5x
Debt/Equity
0.1x
ROE
-93.2%
P/FCF
-0.6x
RSI (14)
37.20
ATR (14)
$0.12
Beta
2.66
50d MA
$1.87
200d MA
$2.18
Avg Volume
33.2K
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
CIK (SEC)
Phone
855 226 9991
400 N Aberdeen St · Chicago, IL 60642 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | AMC | — | -0.51 | — | 1.79 | +1.1% | -4.5% | +7.0% | +18.0% | -6.9% | +1.5% | — |
| May 15, 2026 | AMC | — | -0.63 | — | 1.55 | +0.0% | -10.3% | -1.4% | +3.6% | +6.3% | +6.6% | — |
| Mar 13, 2026 | AMC | -1.80 | -0.80 | +55.6% | 2.80 | +0.0% | -13.9% | -6.6% | +3.1% | +6.0% | -6.9% | — |
| Nov 12, 2025 | AMC | -1.80 | -0.98 | +45.6% | 3.74 | -1.3% | -9.1% | +0.3% | -12.3% | -8.7% | -6.2% | — |
| Aug 14, 2025 | AMC | -1.80 | -0.97 | +46.1% | 4.02 | -0.5% | -9.7% | +2.5% | -1.3% | -4.6% | +4.0% | — |
| May 15, 2025 | AMC | -1.80 | -0.97 | +46.1% | 4.00 | -11.0% | -4.0% | +15.1% | +7.7% | -9.0% | -2.1% | — |
| Mar 20, 2025 | AMC | -0.06 | -0.01 | +83.3% | 13.20 | +1.8% | +2.3% | -4.0% | +0.2% | -1.2% | -3.4% | — |
| Nov 13, 2024 | AMC | -0.15 | -0.06 | +60.0% | 9.23 | -2.5% | -13.8% | -3.9% | +4.4% | -2.4% | -6.0% | — |
| Aug 12, 2024 | AMC | -0.11 | -0.06 | +45.5% | 13.38 | +2.1% | -5.8% | +0.0% | +0.7% | +0.0% | +6.4% | — |
| May 15, 2024 | AMC | -0.13 | -0.20 | -53.8% | 25.40 | +3.1% | -0.9% | -13.0% | -5.5% | +1.4% | +2.1% | — |
| Mar 25, 2024 | AMC | -0.13 | -0.07 | +48.0% | 39.60 | +3.8% | +2.3% | +1.5% | +3.6% | -2.1% | -25.9% | — |
| Feb 12, 2024 | AMC | -0.28 | -0.16 | +42.9% | 57.90 | -1.6% | -4.1% | -1.1% | -2.7% | +0.0% | -3.4% | — |
| Nov 13, 2023 | AMC | -0.28 | -0.16 | +42.9% | 33.60 | +4.5% | -5.4% | +0.0% | -5.7% | -1.0% | +123.2% | — |
| Aug 14, 2023 | AMC | -0.18 | -0.39 | -116.7% | 27.68 | -1.4% | +1.9% | +1.1% | -7.3% | -1.5% | -30.7% | — |
| May 26, 2023 | AMC | -0.18 | -0.11 | +38.9% | 44.10 | +1.4% | -1.4% | +2.8% | -4.7% | +0.7% | +1.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $12.30 | $12.65 | +2.8% | -3.7% | -4.3% | +1.9% | -2.6% | -12.0% |
| Jun 6 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $20.13 | $20.48 | +1.7% | +1.5% | -0.5% | -8.5% | -4.4% | +1.1% |
| Apr 19 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $32.70 | $31.20 | -4.6% | -20.2% | -13.9% | +0.4% | -0.2% | -3.7% |
| Jun 15 | Benchmark | Maintains | Speculative Buy → Speculative Buy | — | $41.10 | $42.00 | +2.2% | -1.5% | -1.5% | -6.8% | +0.8% | +4.0% |
No insider trades available.
8-K
Cardio Diagnostics Holdings, Inc. -- 8-K Filing
Sep 18
8-K · 7.01
! Medium
Cardio Diagnostics Holdings, Inc. -- 8-K 7.01: Regulation FD Disclosure
Aug 20
8-K · 7.01
! Medium
Cardio Diagnostics Holdings Inc. -- 8-K 7.01: Regulation FD Disclosure
Cardio Diagnostics Holdings held a conference call on February 19, 2026 to update investors on its operational status, recent developments, and strategic priorities.
Feb 19
Institutional (13F) — Top 10
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Hrt Financial Lp | 62,482 | $121K | New | Mar 2026 |
| 2 | Renaissance Technologies Llc | 49,200 | $108K | Added | Jun 2026 |
| 3 | Citadel Advisors Llc | 38,142 | $84K | New | Jun 2026 |
| 4 | Blackrock, Inc. | 34,708 | $76K | New | Jun 2026 |
| 5 | Vanguard Capital Management Llc | 20,155 | $44K | — | Jun 2026 |
| 6 | Ubs Group Ag | 9,919 | $19K | Added | Mar 2026 |
| 7 | Morgan Stanley | 200 | $542 | Reduced | Dec 2025 |
| 8 | Wolverine Asset Management Llc | 104 | $203 | — | Mar 2026 |
| 9 | Shp Wealth Management | 16 | $35 | New | Jun 2026 |
| 10 | Sbi Securities Co., Ltd. | 10 | $22 | New | Jun 2026 |
Mutual Funds / ETFs (N-PORT) — Top 5
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 16,558 | $108K | Feb 2026 |
| 2 | Fidelity Series Total Market Index Fund | 2,826 | $5K | May 2026 |
| 3 | Fidelity Total Market Index Fund | 2,251 | $4K | May 2026 |
| 4 | Fidelity Nasdaq Composite Index Fund | 398 | $3K | Feb 2026 |
| 5 | Blackstone Alternative Multi-Strategy Fund | -15 | $-33 | Jun 2026 |
Valuation
Market Cap
$5.5M
Enterprise Value
-$1.7M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.01x
P/B
0.47x
P/S
225.59x
P/FCF
-0.57x
EV/EBITDA
—
Shares Out
1.8M
Financials (TTM)
Revenue
$14K
Net Income
-$6.5M
EBITDA
-$6.2M
Free Cash Flow
-$5.9M
Op Cash Flow
-$5.7M
EPS Basic
$-3.71
EPS Diluted
$-2.92
EPS Forward
$-16.50
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$7.8M
Total Liab.
$793K
Total Equity
$7.0M
Cash
$5.1M
LT Debt
$0
Book Value/Sh
$3.98
Debt/Equity
0.10x
Current Ratio
9.79
Quick Ratio
9.79
Returns & Growth
ROE
-93.2%
ROA
-83.7%
ROIC
-84.5%
Rev Growth YoY
-57.5%
EPS Growth YoY
+60.1%
Price Returns
2W
-5.4%
1M
+4.3%
3M
-3.5%
6M
-5.9%
12M
-54.8%
Technicals
52W High
$7.91
52W Low
$0.97
50d MA
$1.87
200d MA
$2.18
RSI (14)
37.20
ATR (14)
$0.12
Beta
2.66
Avg Volume
33K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 25, 2026 12:29am
· Source: financialmodelingprep.com